Regional risk factors associated with adverse outcomes of COVID-19 infection among the older adult: A systematic review and meta-analysis.

Publication date: Feb 01, 2025

The rapid global spread of Coronavirus Disease 2019 (COVID-19) has resulted in millions of infections and deaths, particularly impacting older adults. This study systematically analyzes risk factors reported in different geographical regions such as Asia and Europe that are associated with adverse outcomes in older adults with COVID-19. Following Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines, we searched five databases up to December 2023 and conducted meta-analyses of odds ratios for 27 risk factors reported in at least two studies using R software (version 4. 3.2). Our meta-analysis identified 19 risk factors linked to adverse outcomes, with many of them common across regions, particularly in Asia and Europe. Key factors include old age (above 65 years), male gender, symptoms such as fever and dyspnea, and comorbidities like dementia, chronic obstructive pulmonary disease (COPD), chronic heart disease, hypertension, chronic kidney disease, and malnutrition. Laboratory biomarkers such as low oxygen saturation, thrombocytopenia, and elevated D-dimer were also associated with adverse outcomes. COVID-19 patients in Asia and Europe who are older adults, male, or have specific symptoms combined with underlying health conditions are at an increased risk of progressing to severe illness or mortality.

Concepts Keywords
Asia Adverse outcome
Coronavirus Age Factors
December Aged
Malnutrition Aged, 80 and over
Thrombocytopenia Asia
Comorbidity
COVID 19
COVID-19
Europe
Female
Humans
Infectious disease
Male
Risk Factors
SARS-CoV-2
Sex Factors

Semantics

Type Source Name
disease MESH COVID-19
disease MESH infection
disease MESH dyspnea
disease MESH dementia
disease MESH chronic obstructive pulmonary disease
disease MESH heart disease
disease MESH hypertension
disease MESH chronic kidney disease
disease MESH malnutrition
drug DRUGBANK Oxygen
disease MESH thrombocytopenia
disease MESH Comorbidity
disease MESH Infectious disease
pathway REACTOME Infectious disease

Original Article

(Visited 2 times, 1 visits today)